Danaher has announced it will spin off its dental business into an independent, publicly traded company called DentalCo. Danaher is the parent company of DEXIS, Nobel Biocare, i-CAT, Pelton & Crane, KaVo Kerr Group, and others.
Amir Aghdaei was named president and CEO of the new company. Aghdaei currently serves as group executive with responsibility for the dental business for Danaher.
The company said the spin-off was expected to be completed in the second half of 2019.
Danaher also announced results for the second fiscal quarter of 2018.
For the quarter (end-June 29), the company reported sales of $4.98 billion, a 10.4% increase compared with $4.51 billion in the same quarter of 2017. Net earnings for the quarter were $673.8 million, up 20% compared with $557.3 million in the corresponding 2017 quarter.
